Open for Enrollment

Maternal Fetal Medicine

• A Randomized trial of 17 alpha-Hydroxyprogesterone Caproate for prevention of preterm birth in Multifetal gestation
• Antenatal Late Preterm Steroids (ALPS): A randomized placebo-controlled trial
• A randomized trial of Fetal ECG ST Segment and T Wave analysis as an adjunct to electronic fetal heart rate monitoring (STAN)
• BSTE -1003 Sample collection study for the assessment of novel biomarkers of placental function and maternal adaptation in healthy pregnant women without Pre-Eclampsia
• A Randomized Trial to Prevent Congenital Cytomegalovirus Infection (CMV)
• An Observational Study of Hepatitis C Virus in Pregnancy
• Non-Invasive Chromosomal Examination of Trisomy - Protocol #TD-007
• A Clinical Study to Evaluate the Clinical Performance of the SEQureDx® Trisomy 21 Test in the Detection of the Relative Quantity of Chromosome 21 in Circulating Cell-Free DNA Extracted from a Maternal Blood Sample Obtained from Pregnant Women with One or More High Risk Indicatoes for Fetal Chromosome 21 Aneuploidy (SQNM-T21-304)
• Comparison of Aneuploidy Risk Evaluations (CARE)Performance of the Verinata Health Prenatal Aneuploidy Test Compared to Current Fetal Aneuploidy Screening Results and Pregnancy Outcomes in an ‘All-Risk’ Population
• The Relationship between Beta-2 Adrenergic Receptor Genotype, Short Cervix and Pregnancy Outcomes in Nulliparous Women (BAR-SCAN)
• A Clinical Study to Evaluate the Relative Clinical Specificity Performance of the SEQureDx® Trisomy 21 Test in Pregnant Women at Low Risk for Fetal Chromosome 21 Aneuploidy (SQNM-T21-303)